Evidence map›Paper›PMID 40278017›Full record

ArticleJournal of imaging2025

Dual-Stream Contrastive Latent Learning Generative Adversarial Network for Brain Image Synthesis and Tumor Classification.

Junaid Zafar, Vincent Koc, Haroon Zafar

Abstract read
In one paragraph

Article in Journal of imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Junaid ZafarFaculty of Engineering, Government College University, Lahore 54000, Pakistan.
Vincent KocIndependent Researcher, Kuala Lumpur 55100, Malaysia.ORCID 0000-0002-7830-0017
Haroon ZafarLambe Institute for Translational Research, University of Galway, H91 YR71 Galway, Ireland.ORCID 0000-0003-0300-7446

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generative adversarial networks (GANs) prioritize pixel-level attributes over capturing the entire image distribution, which is critical in image synthesis. To address this challenge, we propose a dual-stream contrastive latent projection generative adversarial network (DSCLPGAN) for the robust augmentation of MRI images. The dual-stream generator in our architecture incorporates two specialized processing pathways: one is dedicated to local feature variation modeling, while the other captures global structural transformations, ensuring a more comprehensive synthesis of medical images. We used a transformer-based encoder-decoder framework for contextual coherence and the contrastive learning projection (CLP) module integrates contrastive loss into the latent space for generating diverse image samples. The generated images undergo adversarial refinement using an ensemble of specialized discriminators, where discriminator 1 (D1) ensures classification consistency with real MRI images, discriminator 2 (D2) produces a probability map of localized variations, and discriminator 3 (D3) preserves structural consistency. For validation, we utilized a publicly available MRI dataset which contains 3064 T1-weighted contrast-enhanced images with three types of brain tumors: meningioma (708 slices), glioma (1426 slices), and pituitary tumor (930 slices). The experimental results demonstrate state-of-the-art performance, achieving an SSIM of 0.99, classification accuracy of 99.4% for an augmentation diversity level of 5, and a PSNR of 34.6 dB. Our approach has the potential of generating high-fidelity augmentations for reliable AI-driven clinical decision support systems.

Indexed as

brain imagingGANsMRItumor classification

Identifiers

PMID40278017
PMCPMC12027838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.